Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis

Eur J Clin Invest. 1998 Feb;28(2):145-50. doi: 10.1046/j.1365-2362.1998.00257.x.

Abstract

Background: Modulation of cytokine secretion may be of interest in the treatment of Crohn's disease or ulcerative colitis.

Methods: The effect of three antioxidants - butylated hydroxyanisol, tetrahydropapaveroline and nordihydroguaiaretic acid - on the production of tumour necrosis factor (TNF), interleukin (IL) 1, IL-6 and IL-8 (measured by enzyme-linked immunosorbent assay) by peripheral mononuclear cells and biopsies of inflamed colonic mucosa from inflammatory bowel disease patients were studied.

Results: We observed a decrease in IL-1 and IL-6 production by peripheral mononuclear cells from inflammatory bowel disease patients (approximately 50% of control). The three drugs did not decrease IL-6 and IL-8 secretion by colonic biopsies, whereas they did inhibit IL-1 and, to some degree, TNF production. The cytokine-inhibitory effect of antioxidants seems to be more pronounced in ulcerative colitis than in Crohn's disease.

Conclusion: Our results suggest that the studied antioxidants, or related compounds, may be of interest in inflammatory bowel disease treatment.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antioxidants / pharmacology*
  • Butylated Hydroxyanisole / pharmacology
  • Cell-Free System / metabolism
  • Cells, Cultured
  • Colitis, Ulcerative / metabolism*
  • Crohn Disease / metabolism*
  • Cytokines / antagonists & inhibitors*
  • Cytokines / biosynthesis*
  • Dimethyl Sulfoxide / pharmacology
  • Humans
  • Intestinal Mucosa / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Masoprocol / pharmacology
  • Middle Aged
  • Organ Culture Techniques

Substances

  • Antioxidants
  • Cytokines
  • Butylated Hydroxyanisole
  • Masoprocol
  • Dimethyl Sulfoxide